| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/2004 | US6774118 Therapeutic use of CIS-element decoys in vivo |
| 08/10/2004 | US6774116 Prodrugs via acylation with cinnamate |
| 08/10/2004 | US6774115 Bactericides |
| 08/10/2004 | US6774114 Topical application of immixture of ascorbic acid + ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 08/10/2004 | US6774112 Antidiabetic agents; cardiovascular disorders |
| 08/10/2004 | US6774111 Carbohydrate system and a method for providing nutrition to a diabetic |
| 08/10/2004 | US6774107 Protein for blocking platelet adhesion |
| 08/10/2004 | US6774103 Compounds for deactivating phospholamban function on Ca-ATPase (phospholamban inhibitors) |
| 08/10/2004 | US6773924 Such as iron hydroxide and sodium iron gluconate in glucose; blood disorders; storage stability |
| 08/10/2004 | US6773891 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. these conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. the novel conjugates preserve the chirality of nicotine in |
| 08/10/2004 | US6773881 By modulating vascular endothelial growth factor (vegf) |
| 08/10/2004 | US6773729 Administering combination of ginseng and ginkgo to improve the speed of memory and memory quality in normal, healthy subjects and to prevent deterioration of the speed of memory in people with decreased cognitive functions |
| 08/10/2004 | US6773724 Improved solubility |
| 08/10/2004 | US6773720 Inner lipophilic and outher hydrophilic matrixs; high active ingredient content |
| 08/10/2004 | US6773715 Preparation and use of solidified oils |
| 08/10/2004 | US6773709 Chicken embryo lethal (CELO) virus |
| 08/10/2004 | US6773708 Suppression of excessive th1 and stimulation of th2 cell mediated immune responses |
| 08/10/2004 | US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections |
| 08/10/2004 | US6773702 Treating immune suppression in a warm-blooded animal bearing a tumor; immunotherapy |
| 08/10/2004 | CA2311354C Transdermal therapeutic system (tts) containing oxybutynin |
| 08/10/2004 | CA2306008C Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 08/10/2004 | CA2293011C Process for the preparation of n-(amino-4,6-dihalopyrimidine)formamides |
| 08/10/2004 | CA2290125C Method for the preparation of citalopram |
| 08/10/2004 | CA2245169C Process for the preparation of 2,5-disubstituted pyridines |
| 08/10/2004 | CA2234899C Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist, method for preparation and use thereof in the treatment of cardiovascularillnesses |
| 08/10/2004 | CA2191773C Stable gel formulation for topical treatment of skin conditions |
| 08/10/2004 | CA2187024C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 08/10/2004 | CA2163253C N-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-¬¬3,4-methylenedioxy)phenoxy|methyl|piperidine |
| 08/10/2004 | CA2150287C Agent for treating hepato-biliary diseases |
| 08/10/2004 | CA2149013C A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
| 08/10/2004 | CA2147759C Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it |
| 08/10/2004 | CA2136238C Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
| 08/10/2004 | CA2134566C 1-piperazino-1,2-dihydroindene derivatives |
| 08/10/2004 | CA2129101C Synthetic haemophilus influenzae conjugate vaccine |
| 08/10/2004 | CA2124999C Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| 08/10/2004 | CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes |
| 08/10/2004 | CA2092094C Dextrin sulfates as anti-hiv-1 agents and composition thereof |
| 08/09/2004 | CA2538147A1 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 08/08/2004 | CA2619590A1 Solution based methacholine formulations |
| 08/07/2004 | CA2456895A1 Transdermal therapeutic delivery system with a butenolide |
| 08/06/2004 | CA2454337A1 Pharmaceutical compositions for the treatment of movement disorders |
| 08/05/2004 | WO2004065960A1 Novel screening method |
| 08/05/2004 | WO2004065932A2 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 08/05/2004 | WO2004065587A1 Compositions and processes using sirna, amphipathic compounds and polycations |
| 08/05/2004 | WO2004065578A2 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 08/05/2004 | WO2004065539A2 Androgen receptor antagonists |
| 08/05/2004 | WO2004065401A1 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 08/05/2004 | WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 08/05/2004 | WO2004065395A1 Thienopyridazinones and their use in modulation of autoimmune disease |
| 08/05/2004 | WO2004065394A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 08/05/2004 | WO2004065393A1 Novel compounds |
| 08/05/2004 | WO2004065385A1 Novel nitrogen-containing cyclic compounds |
| 08/05/2004 | WO2004065384A1 Nonlinear optical compounds and methods for their preparation |
| 08/05/2004 | WO2004065380A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 08/05/2004 | WO2004065379A1 Androgen receptor antagonists |
| 08/05/2004 | WO2004065358A2 Method of reducing toxicity of retinoids |
| 08/05/2004 | WO2004065355A1 Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester |
| 08/05/2004 | WO2004065353A1 Compounds for the inhibition of rotamases |
| 08/05/2004 | WO2004065348A1 Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof |
| 08/05/2004 | WO2004064869A2 Amyloid-binding, metal-chelating agents |
| 08/05/2004 | WO2004064867A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 08/05/2004 | WO2004064866A1 Combined use of carnosinase inhibitor with l-carnosines and composition |
| 08/05/2004 | WO2004064850A1 Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent |
| 08/05/2004 | WO2004064849A1 Means for normalising structure and functions of organs and tissues, stimulating injury recovery and exhibiting antiviral activity |
| 08/05/2004 | WO2004064848A1 Uses of naringenin, naringin and salts thereof as expectorants in the treatment of cough, and compositions thereof |
| 08/05/2004 | WO2004064847A1 Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers |
| 08/05/2004 | WO2004064846A1 Compositions and methods for combination antiviral therapy |
| 08/05/2004 | WO2004064845A1 Compositions and methods for combination antiviral therapy |
| 08/05/2004 | WO2004064844A1 Method for inhibition of necrosis induced by neurotrophin |
| 08/05/2004 | WO2004064843A2 Compound preparation for dizziness |
| 08/05/2004 | WO2004064841A1 Formulation and methods for the treatment of thrombocythemia |
| 08/05/2004 | WO2004064840A1 Composition for treting hyperlipemia |
| 08/05/2004 | WO2004064839A1 Salts of codrugs of an opioid together with a second active moiety and uses thereto |
| 08/05/2004 | WO2004064838A1 Pharmaceutical compositions and methods for treating multidrug resistant cancer |
| 08/05/2004 | WO2004064837A1 Antibacterial fab i inhibitors |
| 08/05/2004 | WO2004064836A2 Treatment of diseases with alpha-7 nach receptor full agonists |
| 08/05/2004 | WO2004064835A1 Use of ion channel modulating agents for treating pain |
| 08/05/2004 | WO2004064834A1 Co-precipitated amorphous losartan and dosage forms comprising the same |
| 08/05/2004 | WO2004064833A1 Clindamycin phosphate foam |
| 08/05/2004 | WO2004064832A2 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | WO2004064831A1 Compounds having anti-proliferative properties |
| 08/05/2004 | WO2004064830A1 Processed fat compositions for preventing and improving lifestyle-related diseases |
| 08/05/2004 | WO2004064829A1 Method for the medicinal prophylaxis of cholinesterase inhibitor intoxication, and active substances and medicaments suitable therefor |
| 08/05/2004 | WO2004064827A1 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases |
| 08/05/2004 | WO2004064826A1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 08/05/2004 | WO2004064825A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 08/05/2004 | WO2004064824A1 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments |
| 08/05/2004 | WO2004064823A1 Ceramide derivatives for the treatment of inflammation |
| 08/05/2004 | WO2004064822A1 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2004 | WO2004064821A1 Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders |
| 08/05/2004 | WO2004064820A2 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels |
| 08/05/2004 | WO2004064819A1 Sphingolipids for improvement of the composition of the intestinal flora |
| 08/05/2004 | WO2004064818A1 Blood pressure-lowering agent, vascular flexibility-improving agent and foods having these functions imparted thereto |
| 08/05/2004 | WO2004064814A1 Improvements in or relating to anti-aromatase composition |
| 08/05/2004 | WO2004064813A1 Improvements in or relating to anti-aromatase composition |
| 08/05/2004 | WO2004064812A1 Methods and compositions for delivering 5-ht3 antagonists across the oral mucosa |
| 08/05/2004 | WO2004064809A1 Solid pharmaceutical composition comprising ramipril |
| 08/05/2004 | WO2004064808A1 Drug particles obtained by freezing onto a cold surface |
| 08/05/2004 | WO2004064807A1 Sustained-release preparations and method for producing the same |
| 08/05/2004 | WO2004064804A1 Povidone-iodine-based ophthalmological preparations |